The startup utilizes a proprietary Generative Biology Platform and a Discovery Platform that integrate machine learning and multi-modal single-cell analysis to identify gene regulatory networks and develop targeted cell therapies for cancer. By precisely modulating gene expression in specific cell types, the company aims to enhance the efficacy of cell-based treatments, addressing the limitations of traditional cancer therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional cancer therapies often face limitations in efficacy due to their inability to precisely target and modulate gene expression within specific cell types. This lack of specificity can lead to off-target effects and reduced therapeutic outcomes. Existing cell-based treatments also struggle with inconsistent performance and scalability.
Solution
Cellertz Bio is developing targeted cell therapies for cancer by integrating machine learning and multi-modal single-cell analysis to identify key gene regulatory networks. Their approach involves a proprietary Generative Biology Platform and a Discovery Platform that work in tandem to enhance the efficacy of cell-based treatments. The Discovery Platform identifies crucial biological patterns within vast biomedical datasets, reconstructing developmental processes and gene regulatory networks. The Generative Biology Platform then employs deep learning techniques to generate novel molecules with precise properties, offering enhanced control over gene expression in specific cell types.
Target Audience
The primary target audience includes researchers and clinicians focused on developing advanced cell therapies for cancer treatment.
Features
- Proprietary Generative Biology Platform utilizing deep learning to design novel molecules
- Discovery Platform employing multi-modal single-cell analysis to identify gene regulatory networks
- Cell Therapy Platform harnessing the power of the Generative Biology and Gene Discovery platforms
- Reconstruction of developmental processes, gene regulatory networks, and signaling pathways
- Identification of gene expression programs linked to disease onset, progression, stem cell differentiation, and development
- Capability to precisely modulate gene expression in specific cell types